LH vs LUNG · P/E 23, rev $7.27B vs rev $43.3M
Laboratory Corporation of America Holdings (LH) versus Pulmonx Corp (LUNG) — a side-by-side from cached financials, not a winner call.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
Pulmonx Corp (LUNG) is a medical devices company listed on US.
Latest reported LH revenue for 2026-06-30 was $7.27B. Net income was $576.5M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
Latest reported LUNG revenue for 2026-06-30 was $43.3M. Net income was -$23.7M. LUNG currently screens at market cap $111.9M.
LH currently screens at market cap $21.07B and trailing P/E 22.8. LUNG currently screens at market cap $111.9M.
Not investment advice. Open the LH and LUNG stock pages for the full models.
Not investment advice.